BHC News
Corporate Developments Investors Can't Ignore
Across the markets companies are navigating pivotal moments that could shape their future, including NeOnc Technologies (NASDAQ:NTHI), Cemtrex (NASDAQ:CETX), Norwegian Cruise Line (NYSE:NCLH), Nuwellis (NASDAQ:NUWE), Teladoc Health (NYSE:TDOC), Bausch Health (NYSE:BHC), Insmed (NASDAQ:INSM), and Glaukos (NYSE:GKOS).
24-7 Market News
Corporate Developments Investors Can't Ignore
Across the markets companies are navigating pivotal moments that could shape their future, including NeOnc Technologies (NASDAQ:NTHI), Cemtrex (NASDAQ:CETX), Norwegian Cruise Line (NYSE:NCLH), Nuwellis (NASDAQ:NUWE), Teladoc Health (NYSE:TDOC), Bausch Health (NYSE:BHC), Insmed (NASDAQ:INSM), and Glaukos (NYSE:GKOS).
24-7 Market News
BHC Q3 Earnings Beat on Salix Growth, Stock Gains 9% as Outlook Rises
Bausch Health shares jump 9% as Q3 earnings top estimates, driven by Xifaxan-led Salix growth, improved profitability and raised 2026 guidance.
Zacks
Bausch Health (BHC) Surpasses Q3 Earnings and Revenue Estimates
Bausch (BHC) delivered earnings and revenue surprises of +63.89% and +7.11%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Bausch (BHC) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Bausch (BHC) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks
Bausch Health Announces Full Redemption of 8.500% Senior Notes Due 2027
Bausch Health Announces Full Redemption of 8.500% Senior Notes Due 2027 Bausch Health Announces Full Redemption of 8.500% Senior Notes Due 2027PR NewswireLAVAL, QC, Oct. 28, 2026 LAVAL, QC, Oct. 28, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that its...
PR Newswire
Bausch Health Announces US$50 Million Share Repurchase Program
Bausch Health Announces US$50 Million Share Repurchase Program Bausch Health Announces US$50 Million Share Repurchase ProgramPR NewswireLAVAL, QC, Oct. 28, 2026 LAVAL, QC, Oct. 28, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that its Board of Directors has...
PR Newswire
BAUSCH HEALTH ANNOUNCES THIRD QUARTER 2026 RESULTS, RAISES GUIDANCE
BAUSCH HEALTH ANNOUNCES THIRD QUARTER 2026 RESULTS, RAISES GUIDANCE BAUSCH HEALTH ANNOUNCES THIRD QUARTER 2026 RESULTS, RAISES GUIDANCEPR NewswireLAVAL, QC, Oct. 28, 2026 Third Quarter Consolidated Revenues of $2.94 billion, up 10% on a Reported basis and 8% on an Organic1basis over the prior year...
PR Newswire
BHC Q3 Earnings Preview: Here's What You Should Know
Bausch Health reports Q3 2026 results on Oct. 28, with $2.75 billion in expected sales. Explore key segment drivers and mixed earnings surprise history.
Zacks
Bausch Health Pilot Study Shows Improved Cirrhosis Care Adherence
(RTTNews) - Bausch Health Companies Inc. (BHC, BHC.TO) and its gastroenterology unit Salix Pharmaceuticals, announced on Monday that a six-month pilot study of a standardized clinical pathway for Cirrhosis management improved adherence to guideline-based monitoring and treatment...
Nasdaq News: Markets
Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical Pathway
Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical Pathway Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical PathwayPR NewswireLAVAL, QC, Oct. 12...
PR Newswire